Verona Pharma PLC Holding(s) in Company (8336F)
August 01 2016 - 6:20AM
UK Regulatory
TIDMVRP
RNS Number : 8336F
Verona Pharma PLC
01 August 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Verona Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------------- -----------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
--------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
---------------------------------------------------------------- --------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
---------------------------------------------------------------- --------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
---------------------------------------------------------------- --------------------------------
An event changing the breakdown of voting rights
---------------------------------------------------------------- --------------------------------
Other (please
specify):
--------------------------------------------------------- ----- --------------------------------
3. Full name of person(s) Abingworth LLP
subject to the Abingworth Bioventures VI
notification obligation: LP
(iii)
----------------------------------------------------------- -------------------------------------
4. Full name of shareholder(s) State Street (Nominees) Limited
(if different from 3.):(iv) (as nominee for Abingworth
Bioventures V LP)
----------------------------------------------------------- -------------------------------------
5. Date of the transaction 29 July 2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- -------------------------------------
6. Date on which issuer 29 July 2016
notified:
----------------------------------------------------------- -------------------------------------
7. Threshold(s) that is/are Above 3%, 4%, 5%, 6%
crossed or
reached: (vi, vii)
----------------------------------------------------------- -------------------------------------
8. Notified details: Abingworth LLP
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- ---------------------------------- ------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
-------------- ---------------- ---------------- -------------- ----------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------- ------------ ------------ -------------- --------- ------------ ------------ -----------
Verona Pharma
plc 0 0 175,527,671 175,527,671 6.84%
GB00B06GSH43
0.1p Ords
---------------- ---------------- -------------- --------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------ -------------- -------------------------------- ------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
---------------- -------------- -------------- ---------------- ------------------------- -----------------------
Nominal Delta
---------------- -------------- -------------- ---------------- ------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
---------------------------------------------------- ----------------------------------------------------------------
175,527,671 6.84%
---------------------------------------------------- ----------------------------------------------------------------
8. Notified details: Abingworth Bioventures VI LP
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- -------------------------------- --------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
-------------- --------------- --------------- -------------- -------------------------- ------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------- ----------- ----------- -------------- -------------- ---------- ------------ ----------
Verona Pharma
plc 0 0 175,527,671 175,527,671 6.84%
GB00B06GSH43
0.1p Ords
--------------- --------------- -------------- -------------- ---------- ------------ ----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------ ------------- ------------------------------- ---------------------------- --------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
---------------- ------------- ------------- ---------------- ---------------------------- ----------------------
Nominal Delta
---------------- ------------- ------------- ---------------- ---------------------------- ---------- ----------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
-------------------------------------------------- ------------------------------------------------------------------
175,527,671 6.84%
-------------------------------------------------- ------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
----------------------------------------------------------------------------------------------------------------------
Abingworth Bioventures VI LP (which holds 175,527,671
shares in the company (6.84%)) is managed by Abingworth
LLP.
Proxy Voting:
----------------------------------------------------------------------------------------------------------------------
10. Name of the proxy holder:
-------------------------------------------------------------------------------- ------------------------------------
11. Number of voting rights proxy
holder will cease
to hold:
-------------------------------------------------------------------------------- ------------------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
-------------------------------------------------------------------------------- ------------------------------------
13. Additional information:
-------------------------------------------------- ------------------------------------------------------------------
14. Contact name: John Heard
-------------------------------------------------- ------------------------------------------------------------------
15. Contact telephone number: 020 7534 1500
-------------------------------------------------- ------------------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUGUAGRUPQGUG
(END) Dow Jones Newswires
August 01, 2016 06:20 ET (10:20 GMT)
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jul 2023 to Jul 2024
